Inno Pharma SRL
Inno Pharma reported total assets of 1,245 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026).
The score of Inno Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +60 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inno Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
Inno Pharma's financial analysis
- Solvency-157.0%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inno Pharma
Inno Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.694.073
- VAT number
- BE0762694073
- Peppol
- Registered · 0208:0762694073 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jan 2021
- Registered office
- 2870 Puurs-Sint-Amands
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Inno Pharma (SRL) has been based in Puurs-Sint-Amands since 2021, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 830 € and equity of −1,955 €; its revenue is not published. Its solvency stands at -157.0%, below the median of its sector (56.0%).
Companies similar to Inno Pharma
Companies in the same business, of comparable size and area, outside its group.
- Quantoom Bioservices Manufacture of basic pharmaceutical products Nivelles · balance sheet 59,035 €
- Raya Therapeutic Manufacture of basic pharmaceutical products Leuven · balance sheet 5,330 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- Eurandlab Manufacture of pharmaceutical preparations Charleroi · balance sheet 27,845 €
- Pledge Therapeutics Manufacture of basic pharmaceutical products Leuven · balance sheet 229,854 €
- Pranarom MED Manufacture of basic pharmaceutical products Ath · balance sheet 24,820 €
- Premium Pharma Retail Manufacture of basic pharmaceutical products Molenbeek-Saint-Jean · balance sheet 34,216 €
Frequently asked questions about Inno Pharma
What is the revenue of Inno Pharma?
Inno Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Inno Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0762694073 for Inno Pharma, if the company is VAT-registered. Its company number (CBE) is 0762.694.073.
Where is the registered office of Inno Pharma?
According to the CBE register, the registered office of Inno Pharma is in 2870 Puurs-Sint-Amands.
What is the equity of Inno Pharma?
At the close of the 2025 financial year, the equity of Inno Pharma amounts to -1,955 €, a solvency of -157.0% of total assets.
Who manages Inno Pharma?
The register lists 4 active mandates at Inno Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inno Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →